分析前标本分流:涂片、细胞块、细胞离心制片、转运培养基与细胞生物样本库
该综述指出,随着预后与预测性分子生物标志物检测需求增加,必须重视细胞学标本在样本质量及DNA/RNA产量方面的分析前问题。文章更新了标本分流、处理与采集的重要性,讨论了可用于分子检测的不同细胞制片类型的优缺点,并强调了细胞学样本生物样本库的策略。
要点
- 新鲜细胞悬液、FFPE细胞块、存档染色涂片、存档未染色细胞离心制片、液基细胞学玻片、FTA卡及冷冻保存细胞均可获取高质量DNA/RNA。
- 与FFPE组织标本相比,细胞学标本制备类型多样且采集处理流程差异大,使其成为大多数基因组平台的理想标本,DNA和RNA降解更少、样本更纯且肿瘤细胞浓度通常更高。
- 将细胞学标本广泛纳入临床实践可增加可用于分子检测的样本数量,避免重复有创取材,从而提高患者安全。
核心结论
- 细胞学标本因制备类型多样、采集处理差异大,成为大多数基因组平台的理想标本,DNA和RNA降解更少、样本更纯且肿瘤细胞浓度通常更高。
- 广泛将细胞学标本纳入临床实践可增加分子检测可用样本量,避免重复有创取材,提高患者安全。
- 细胞病理学家必须熟悉影响检测结果的变量,并追求样本质量的卓越。
研究设计与样本
- 综述,旨在更新标本分流、处理与采集的重要性,讨论不同细胞制片用于分子检测的优缺点,并强调细胞学样本生物样本库策略。
主要发现
- 新鲜细胞悬液、FFPE细胞块、存档染色涂片、存档未染色细胞离心制片、液基细胞学玻片、FTA卡及冷冻保存细胞均可获取高质量DNA/RNA。
- 与FFPE组织标本(小活检和手术切除)相比,细胞学标本制备类型多样且采集处理流程差异大,使其成为大多数基因组平台的理想标本。
临床怎么用
- 将细胞学标本广泛纳入临床实践,以增加可用于分子检测的样本数量并避免重复有创取材。
- 细胞病理学家应熟悉影响检测结果的变量,并致力于追求样本质量的卓越。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With increasing requests for the evaluation of prognostic and predictive molecular biomarkers, great attention must be paid to the preanalytical issues regarding sample quality and DNA/RNA yield from all different types of cytological preparations. The objectives of this review were: 1) to provide an update regarding the importance of specimen triage as well as specimen handling and collection; 2) to discuss the different cell preparations that can be used for molecular testing, their advantages and limitations; and 3) to highlight the strategies for biobanking cytology samples. Good-quality DNA/RNA can be harvested from fresh cells in cell suspensions, formalin-fixed paraffin-embedded cell blocks, archival stained smears, archival unstained cytospin preparations, liquid-based cytology slides, FTA cards, and cryopreserved cells. In contrast to formalin-fixed paraffin-embedded tissue specimens (small biopsies and surgical resections), the multitude of types of sample preparations as well as the diversity in sample collection and processing procedures make cytology an ideal specimen for most genomic platforms, with less DNA and RNA degradation and a purer sample, usually with a higher concentration of tumor cells. The broad incorporation of cytological specimens into clinical practice. A should increase the number of samples potentially available for molecular tests and avoid repeat invasive procedures for tissue procurement, thereby increasing patient safety. In this context, it is of utmost importance that cytopathologists become familiar with the variables that can affect test results and embrace the goal of excellence in sample quality. Cancer Cytopathol 2017;125(6 suppl):455-64. © 2017 American Cancer Society.
引用
- da Cunha Santos G, Saieg MA. Preanalytic specimen triage: Smears, cell blocks, cytospin preparations, transport media, and cytobanking. Cancer Cytopathol. 2017. PMID: 28609003. doi:10.1002/cncy.21850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。